Erythropoietin in Preterm Infants. - Suppr | 超能文献

Erythropoietin in Preterm Infants.

作者信息

Ehrenreich Hannelore, Neubauer Achim-Peter, Miskowiak Kamilla

机构信息

Max Planck Institute of Experimental Medicine, Göttingen, Germany

Children's Hospital Auf der Bult, Hannover, Germany.

出版信息

N Engl J Med. 2020 May 7;382(19):1862. doi: 10.1056/NEJMc2002493.

DOI:10.1056/NEJMc2002493

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Erythropoietin in Preterm Infants.

N Engl J Med. 2020 May 7;382(19):1862. doi: 10.1056/NEJMc2002493.

2

Erythropoietin in Preterm Infants. Reply.早产儿中的促红细胞生成素。回复。

N Engl J Med. 2020 May 7;382(19):1862-1863. doi: 10.1056/NEJMc2002493.

3

Tract-based spatial statistics to assess the neuroprotective effect of early erythropoietin on white matter development in preterm infants.基于束流的空间统计学评估早期促红细胞生成素对早产儿脑白质发育的神经保护作用。

Brain. 2015 Feb;138(Pt 2):388-97. doi: 10.1093/brain/awu363. Epub 2014 Dec 22.

4

Factors associated with successful epoetin alfa therapy in premature infants.与早产儿促红细胞生成素α治疗成功相关的因素。

Ann Pharmacother. 2000 Apr;34(4):433-9. doi: 10.1345/aph.19169.

5

Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age.早产儿早期给予高剂量促红细胞生成素与胎龄相当足月时脑 MRI 异常的相关性研究。

JAMA. 2014 Aug 27;312(8):817-24. doi: 10.1001/jama.2014.9645.

6

Erythropoietin for Neuroprotection in preterm infants.促红细胞生成素对早产儿的神经保护作用

Ann Neurol. 2016 Dec;80(6):952. doi: 10.1002/ana.24787. Epub 2016 Oct 19.

7

Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.早期与晚期使用促红细胞生成素预防早产和/或低出生体重儿的红细胞输血

Cochrane Database Syst Rev. 2020 Feb 11;2(2):CD004865. doi: 10.1002/14651858.CD004865.pub4.

8

Population pharmacodynamic analysis of erythropoiesis in preterm infants for determining the anemia treatment potential of erythropoietin.早产儿红细胞生成的群体药代动力学分析，以确定促红细胞生成素治疗贫血的潜力。

Am J Physiol Regul Integr Comp Physiol. 2013 May 1;304(9):R772-81. doi: 10.1152/ajpregu.00173.2012. Epub 2013 Mar 13.

9

[Recombinant human erythropoietin--blood transfusion alternative].

Antibiot Khimioter. 2000;45(12):27-9.

10

Neuroprotection with erythropoietin in preterm and/or low birth weight infants.促红细胞生成素对早产和/或低出生体重婴儿的神经保护作用。

J Clin Neurosci. 2014 Aug;21(8):1283-7. doi: 10.1016/j.jocn.2013.10.040. Epub 2014 Feb 6.

引用本文的文献

1

Cytokine dysregulation in children with severe neurological impairment correlates with significant clinical outcomes.患有严重神经功能障碍的儿童体内细胞因子失调与显著的临床结果相关。

Front Pediatr. 2025 Jun 30;13:1567221. doi: 10.3389/fped.2025.1567221. eCollection 2025.

2

Erythropoietin as candidate for supportive treatment of severe COVID-19.促红细胞生成素作为治疗严重 COVID-19 的支持性治疗候选药物。

Mol Med. 2020 Jun 16;26(1):58. doi: 10.1186/s10020-020-00186-y.